Home Amines 82560-12-1
82560-12-1,MFCD00067987
Catalog No.:AA0033IG

82560-12-1 | 3-Amino-5-tert-butylpyrazole

Pack Size
Purity
Availability
Price(USD)
Quantity
  
10g
95%
in stock  
$9.00   $6.00
- +
100g
98%
in stock  
$79.00   $55.00
- +
500g
98%
in stock  
$261.00   $183.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA0033IG
Chemical Name:
3-Amino-5-tert-butylpyrazole
CAS Number:
82560-12-1
Molecular Formula:
C7H13N3
Molecular Weight:
139.1982
MDL Number:
MFCD00067987
SMILES:
CC(c1[nH]nc(c1)N)(C)C
Properties
Properties
 
Form:
Solid  
MP:
60 °C  
Storage:
Keep in dry area;Room Temperature;  

Computed Properties
 
Complexity:
117  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
10  
Hydrogen Bond Acceptor Count:
2  
Hydrogen Bond Donor Count:
2  
Rotatable Bond Count:
1  
XLogP3:
1.6  

Downstream Synthesis Route
1968-40-7    82560-12-1   
N-<3-(t-butyl)-1H-pyrazol-5-yl>-4-pentenamide 

[1]Brinkmeyer,RaymondS.;Terando,NormanH.[JournalofHeterocyclicChemistry,1989,vol.26,p.1713-1717]

[1]Kirschke,Klaus;Wolff,Erich;Ramm,Matthias;Lutze,Gerhard;Schulz,Burkhard[LiebigsAnnalenderChemie,1994,#10,p.1037-1042]

[1]Kirschke,Klaus;Wolff,Erich;Ramm,Matthias;Lutze,Gerhard;Schulz,Burkhard[LiebigsAnnalenderChemie,1994,#10,p.1037-1042]

[1]Clarke,David;Mares,RichardW.;McNab,Hamish[JournaloftheChemicalSociety.PerkintransactionsI,1997,#12,p.1799-1804]

[1]Bagley,MarkC.;Davis,Terence;Dix,MatthewC.;Widdowson,CarolineS.;Kipling,David[OrganicandBiomolecularChemistry,2006,vol.4,#22,p.4158-4164]

[2]CurrentPatentAssignee:MERCK&COINC-WO2010/104933,2010,A1Locationinpatent:Page/Pagecolumn240

[3]CurrentPatentAssignee:GruenenthalPharmaGmbH&Co.Kommanditgesellschaft-WO2010/127855,2010,A1Locationinpatent:Page/Pagecolumn95

[4]CurrentPatentAssignee:MEDIFRONDBTCO.,LTD.-WO2010/127856,2010,A1Locationinpatent:Page/Pagecolumn78

[5]CurrentPatentAssignee:GruenenthalPharmaGmbH&Co.Kommanditgesellschaft-US2012/46301,2012,A1Locationinpatent:Page/Pagecolumn29

[6]CurrentPatentAssignee:GruenenthalPharmaGmbH&Co.Kommanditgesellschaft-US2012/115903,2012,A1Locationinpatent:Page/Pagecolumn33

[7]CurrentPatentAssignee:GruenenthalPharmaGmbH&Co.Kommanditgesellschaft-WO2012/62462,2012,A1Locationinpatent:Page/Pagecolumn73

[8]CurrentPatentAssignee:GruenenthalPharmaGmbH&Co.Kommanditgesellschaft-US2012/115893,2012,A1Locationinpatent:Page/Pagecolumn29

[9]CurrentPatentAssignee:GruenenthalPharmaGmbH&Co.Kommanditgesellschaft-WO2013/13815,2013,A1Locationinpatent:Page/Pagecolumn104

[10]CurrentPatentAssignee:GruenenthalPharmaGmbH&Co.Kommanditgesellschaft-US2013/29962,2013,A1Locationinpatent:Paragraph0668

[11]CurrentPatentAssignee:GruenenthalPharmaGmbH&Co.Kommanditgesellschaft-WO2013/68463,2013,A1Locationinpatent:Page/Pagecolumn46

[12]CurrentPatentAssignee:MEDIFRONDBTKR-WO2013/68461,2013,A1Locationinpatent:Page/Pagecolumn67

[13]CurrentPatentAssignee:GruenenthalPharmaGmbH&Co.Kommanditgesellschaft-WO2013/68467,2013,A1Locationinpatent:Page/Pagecolumn48

[14]CurrentPatentAssignee:GruenenthalPharmaGmbH&Co.Kommanditgesellschaft-WO2013/68462,2013,A1Locationinpatent:Page/Pagecolumn56

[15]Kelada,Mark;Walsh,JohnM.D.;Devine,RobertW.;McArdle,Patrick;Stephens,JohnC.[BeilsteinJournalofOrganicChemistry,2018,vol.14,p.122-1228]

[16]Charleton,Clara;Conway,GillianE.;Cullen,PatrickJ.;Curtin,JamesF.;Devereux,Michael;Devine,RobertW.;Gunes,Sebnem;He,Zhonglei;Kelada,Mark;Kinsella,GemmaK.;Malone,Renee;Mondala,JulieRoseMae;O'Shea,Denis;Stephens,JohnC.;Tian,Furong;Tiwari,Brijesh;Walsh,JohnM.D.;Wang,Wenxin[EuropeanJournalofMedicinalChemistry,2021,vol.224]

[17]Blake,AlexanderJ.;Clarke,David;Mares,RichardW.;McNab,Hamish[OrganicandBiomolecularChemistry,2003,vol.1,#23,p.4268-4274]

[18]Montalban,AntonioGarrido;Boman,Erik;Chang,Chau-Dung;Ceide,SusanaConde;Dahl,Russell;Dalesandro,David;Delaet,NancyG.J.;Erb,Eric;Ernst,JustinT.;Gibbs,Andrew;Kahl,Jeffrey;Kessler,Linda;Lundstroem,Jan;Miller,Stephen;Nakanishi,Hiroshi;Roberts,Edward;Saiah,Eddine;Sullivan,Robert;Wang,Zhijun;Larson,ChristopherJ.[BioorganicandMedicinalChemistryLetters,2008,vol.18,#6,p.1772-1777]

[19]Locationinpatent:schemeortableAbonia,Rodrigo;Cortes,Edwar;Insuasty,Braulio;Quiroga,Jairo;Nogueras,Manuel;Cobo,Justo[EuropeanJournalofMedicinalChemistry,2011,vol.46,#9,p.4062-4070]

[20]CurrentPatentAssignee:GruenenthalPharmaGmbH&Co.Kommanditgesellschaft-WO2012/62463,2012,A1Locationinpatent:Page/Pagecolumn72

[21]Bera,Hriday;Ojha,ProbirKumar;Tan,BeeJen;Sun,Lingyi;Dolzhenko,AntonV.;Chui,Wai-Keung;Chiu,GigiNgarChee[EuropeanJournalofMedicinalChemistry,2014,vol.78,p.294-303]

[22]Lee,Sunho;Kim,Changhoon;Ann,Jihyae;Thorat,ShivajiA.;Kim,Eunhye;Park,Jongmi;Choi,Sun;Blumberg,PeterM.;Frank-Foltyn,Robert;Bahrenberg,Gregor;Stockhausen,Hannelore;Christoph,Thomas;Lee,Jeewoo[BioorganicandMedicinalChemistryLetters,2017,vol.27,#18,p.4383-4388]

Literature

Title: Synthesis and chemistry of 3-tert-butyl-1,5-diaminopyrazole.

Journal: Organic & biomolecular chemistry 20031207

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:82560-12-1 Molecular Formula|82560-12-1 MDL|82560-12-1 SMILES|82560-12-1 3-Amino-5-tert-butylpyrazole |Heterocyclic_Building_Blocks